Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Controlled_substance_schedule
|
| gptkbp:administeredBy |
gptkb:Drug_Enforcement_Administration
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:dateEnacted |
1970
|
| gptkbp:enactedBy |
gptkb:United_States_Congress
|
| gptkbp:example |
gptkb:Cocaine
gptkb:Adderall gptkb:Amphetamine gptkb:Hydromorphone gptkb:Methylphenidate gptkb:Morphine gptkb:Oxycodone Methamphetamine Fentanyl Codeine (high dose) |
| gptkbp:legalStatus |
Prescription only
|
| gptkbp:partOf |
gptkb:Controlled_Substances_Act
|
| gptkbp:prescriptionDurationLimit |
30 days
|
| gptkbp:prescriptionRefillsAllowed |
No
|
| gptkbp:regulates |
Drugs with accepted medical use
Drugs with high potential for abuse Drugs with severe psychological or physical dependence risk |
| gptkbp:bfsParent |
gptkb:Cocaine
gptkb:Vicodin |
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Schedule II (US)
|